Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study.

MLA

Kranidioti, Hariklia, et al. “Successful Therapy with Tenofovir Disoproxil Fumarate (TDF) in Patients with Chronic Hepatitis B (CHB) Does Not Guarantee Amelioration of Liver Damage Assessing by Transient Elastography. A Retrospective - Prospective Multicenter Study.” BMC Gastroenterology, vol. 24, no. 1, Apr. 2024, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12876-024-03200-3.

APA

Kranidioti, H., Zisimopoulos, K., Oikonomou, T., Voulgaris, T., Siakavellas, S., Agorastou, P., Deutsch, M., Triantos, C., Goulis, I., Papatheodoridis, G., & Manolakopoulos, S. (2024). Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study. BMC Gastroenterology, 24(1), 1–8. https://doi.org/10.1186/s12876-024-03200-3

Chicago

Kranidioti, Hariklia, Konstantinos Zisimopoulos, Theodora Oikonomou, Theodoros Voulgaris, Spyros Siakavellas, Polixeni Agorastou, Melanie Deutsch, et al. 2024. “Successful Therapy with Tenofovir Disoproxil Fumarate (TDF) in Patients with Chronic Hepatitis B (CHB) Does Not Guarantee Amelioration of Liver Damage Assessing by Transient Elastography. A Retrospective - Prospective Multicenter Study.” BMC Gastroenterology 24 (1): 1–8. doi:10.1186/s12876-024-03200-3.